CERESCAN

Lobbying Spend

—

Filings

Firms Hired

Active Period

2011–2026

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2026	—	3	1
2025	—	4	1
2024	—	4	1
2023	—	4	1
2022	—	5	1
2021	—	4	1
2020	—	5	1
2019	—	4	1
2018	—	4	1
2017	—	5	1
2016	—	4	1
2015	—	7	2
2014	—	8	2
2013	—	4	1
2012	—	4	1
2011	—	2	1

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
BELL & LINDSAY, INC. (FORMERLY WHITE HOUSE CONSULTING INC.)	—	64
J M BURKMAN & ASSOCIATES	—	7

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	69
SENATE	69
Food & Drug Administration (FDA)	36
Executive Office of the President (EOP)	21
White House Office	21
Defense, Dept of (DOD)	6
Health & Human Services, Dept of (HHS)	6

Most frequently reported lobbying issues

CERESCAN — Lobbying Disclosure | Poliscope